Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers;Differenzierung von malignen und nichtmalignen, inflammatorischen Perikardergüssen mit Biomarkern

Herz

Volumn 34, Issue 8, 2009, Pages 624-633

  Karatolios, Konstantinos ^a   Alter, Peter ^a   Maisch, Bernhard ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Biomarkers; Cardiac magnetic resonance tomography; Cytokines; Pericardial effusion; Pericardial effusion analysis

Indexed keywords

ADENOSINE DEAMINASE; AUTOANTIBODY; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; INTERFERON; LACTATE DEHYDROGENASE; LYSOZYME; TUMOR MARKER;

BENIGN TUMOR; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; HEART FAILURE; HUMAN; IMMUNITY; INFLAMMATION; ISCHEMIC HEART DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PROGNOSIS; PROTEIN BLOOD LEVEL; RELATIVE DENSITY; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULOUS PERICARDITIS;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HEART NEOPLASMS; HUMANS; MYOCARDITIS; PERICARDIAL EFFUSION; SENSITIVITY AND SPECIFICITY;

EID: 73649117801     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3304-8     Document Type: Review

References (37)

1. C. Aggeli C. Pitsavos S. Brili, et al. 2000 Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis Cardiology 94 81 85 10.1159/000047296 1:CAS:528:DC%2BD3MXps1WksQ%3D%3D 11173777 (Pubitemid 32110326)
2. C.E. Angermann G. Ertl 2004 Natriuretic peptides - new diagnostic markers in heart disease Herz 29 609 617 10.1007/s00059-004-2619-8 15912436 (Pubitemid 39366051)
3. L. Axel 2004 Assessment of pericardial disease by magnetic resonance and computed tomography J Magn Reson Imaging 19 816 826 10.1002/jmri.20076 15170786 (Pubitemid 38788661)
4. S. Ben-Horin I. Bank A. Shinfeld, et al. 2007 Diagnostic value of the biochemical composition of pericardial effusions in pa tients undergoing pericardiocentesis Am J Cardiol 99 1294 1297 10.1016/j.amjcard.2006.12.048 1:CAS:528:DC%2BD2sXkvFGmtbg%3D 17478160 (Pubitemid 46659867)
5. S. Ben-Horin A. Shinfeld E. Kachel, et al. 2005 The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions Am J Med 118 636 640 10.1016/j.amjmed.2005.01.066 15922695 (Pubitemid 40732703)
6. T.S. Bishiniotis S. Antoniadou G. Katseas, et al. 2000 Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa) Am J Cardiol 86 362 364 10.1016/S0002-9149(00)00937-1 1:CAS:528:DC%2BD3cXltVGru7o%3D 10922456 (Pubitemid 30462244)
7. L.J. Burgess H. Reuter M.E. Carstens, et al. 2002 The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis Chest 122 900 905 10.1378/chest.122.3.900 1:CAS:528:DC%2BD38XnvVerurw%3D 12226030
8. L.J. Burgess H. Reuter J.J. Taljaard, et al. 2002 Role of biochemical tests in the diagnosis of large pericardial effusions Chest 121 495 499 10.1378/chest.121.2.495 1:CAS:528:DC%2BD38XitVWmsbw%3D 11834663 (Pubitemid 34132989)
9. M. Colleoni G. Martinelli F. Beretta, et al. 1998 Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen J Clin Oncol 16 2371 2376 1:CAS:528:DyaK1cXks1Gntb4%3D 9667253
10. G.R. Corey P.T. Campbell P. Van Trigt, et al. 1993 Etiology of large pericardial effusions Am J Med 95 209 213 10.1016/0002-9343(93)90262-N 1:STN:280:DyaK3szmt1Kktg%3D%3D 8356985 (Pubitemid 23242715)
11. U. Hoffmann S. Globits W. Schima, et al. 2003 Usefulness of magnetic resonance imaging of cardiac and paracardiac masses Am J Cardiol 92 890 895 10.1016/S0002-9149(03)00911-1 14516903 (Pubitemid 37163597)
12. M.S. Horowitz R. Rossen D.C. Harrison 1979 Echocardiographic diagnosis of pericardial disease Am Heart J 97 420 427 10.1016/0002-8703(79)90386-7 1:STN:280:DyaE1M7kt1amtA%3D%3D 425875 (Pubitemid 10217565)
13. K. Karatolios B. Maisch 2007 Pericardiocentesis Dtsch Med Wochenschr 132 1707 1710 10.1055/s-2007-984955 1:STN:280:DC%2BD2svpsFaltw%3D%3D 17713869 (Pubitemid 47434867)
14. K.P. Karatolios S. Timmesfeld N. Richter, et al. 2008 Diagnostic value of tumor markers in the pericardial fluid for the diagnosis of malignant pericardial effusions Eur Heart J 29 Suppl1 901 962
15. K.K. Koh E.J. Kim C.H. Cho, et al. 1994 Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis Circulation 89 2728 2735 1:STN:280: DyaK2c3msFegsg%3D%3D 8205688
16. J.G. Krikorian E.W. Hancock 1978 Pericardiocentesis Am J Med 65 808 814 10.1016/0002-9343(78)90800-8 1:STN:280:DyaE1M%2FjvFelsw%3D%3D 707539
17. J.H. Lee C.W. Lee S.G. Lee, et al. 2002 Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis Am J Med 113 519 521 10.1016/S0002- 9343(02)01261-5 1:CAS:528:DC%2BD38XosFCktbw%3D 12427503 (Pubitemid 35335806)
18. R.W. Light 1997 Diagnostic principles in pleural disease Eur Respir J 10 476 481 10.1183/09031936.97.10020476 1:STN:280:DyaK2s7psFantw%3D%3D 9042652 (Pubitemid 27063871)
19. J.A. Lima M.Y. Desai 2004 Cardiovascular magnetic resonance imaging: current and emerging applications J Am Coll Cardiol 44 1164 1171 10.1016/j.jacc.2004.06.033 15364314 (Pubitemid 39208868)
20. Maisch B, Seferovic PM. Interventional pericardiology. Berlin-Heidelberg-New York: Springer Verlag 2009: in press.
21. B. Maisch A.D. Ristic S. Pankuweit, et al. 2002 Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin Eur Heart J 23 1625 1631 10.1053/euhj.2002.3328 1:CAS:528:DC%2BD38Xos1WgtLc%3D 12323163 (Pubitemid 35221568)
22. B. Maisch P.M. Seferovic A.D. Ristic, et al. 2004 Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur Heart J 25 587 610 10.1016/j.ehj.2004.02.002 15120056 (Pubitemid 38478552)
23. R. Maksimovic T. Dill P.M. Seferovic, et al. 2006 Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value Herz 31 708 714 10.1007/s00059-006-2894-7 17072787 (Pubitemid 44672098)
24. A. Martinoni C.M. Cipolla D. Cardinale, et al. 2004 Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa Chest 126 1412 1416 10.1378/chest.126.5.1412 15539706 (Pubitemid 39525010)
25. D.G. Meyers D.J. Bouska 1989 Diagnostic usefulness of pericardial fluid cytology Chest 95 1142 1143 10.1378/chest.95.5.1142 1:STN:280: DyaL1M3htVSlug%3D%3D 2651039
26. D.G. Meyers R.E. Meyers T.W. Prendergast 1997 The usefulness of diagnostic tests on pericardial fluid Chest 111 1213 1221 10.1378/chest.111.5. 1213 1:CAS:528:DyaK2sXjtlOjtrw%3D 9149572
27. A. Millaire A. Wurtz P. de Groote, et al. 1992 Malignant pericardial effusions: usefulness of pericardioscopy Am Heart J 124 1030 1034 10.1016/0002-8703(92)90988-8 1:STN:280:DyaK38vhtFWisQ%3D%3D 1529876
28. A.S. Mistchenko A.F. Maffey G. Casal, et al. 1995 Adenoviral pericarditis: high levels of interleukin 6 in pericardial fluid Pediatr Infect Dis J 14 1007 1009 1:STN:280:DyaK287kslGnsg%3D%3D 8584341
29. S. Pankuweit A. Wadlich E. Meyer, et al. 2000 Cytokine activation in pericardial fluids in different forms of pericarditis Herz 25 748 754 10.1007/PL00001993 1:STN:280:DC%2BD3M7ksleltw%3D%3D 11200123
30. H.L. Porte T.J. Janecki-Delebecq L. Finzi, et al. 1999 Pericardoscopy for primary management of pericardial effusion in cancer patients Eur J Cardiothorac Surg 16 287 291 10.1016/S1010-7940(99)00204-3 1:STN:280: DC%2BD3c%2FitFeitA%3D%3D 10554845 (Pubitemid 29443963)
31. R.D. Rifkin D.B. Mernoff 2005 Noninvasive evaluation of pericardial effusion composition by computed tomography Am Heart J 149 1120 1127 10.1016/j.ahj.2004.08.028 15976797 (Pubitemid 40848159)
32. J. Schulz-Menger B. Maisch H. Abdel-Aty, et al. 2007 Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers - a stepwise approach for diagnosis and treatment Herz 32 458 472 10.1007/s00059-007-3046-4 17882371 (Pubitemid 47468955)
33. N. Shikama T. Terano A. Hirai 2000 A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid Heart 83 711 712 10.1136/heart.83.6.711 1:STN:280:DC%2BD3c3ns1ajtA%3D%3D 10814639
34. M. Szturmowicz W. Tomkowski A. Fijalkowska, et al. 1997 The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis Int J Biol Markers 12 96 101 1:STN:280:DyaK1c7ktVaitQ%3D%3D 9479590
35. L.M. Vila J.R. Rivera del Rio Z. Rios, et al. 1999 Lymphocyte populations and cytokine concentrations in pericardial fluid from a systemic lupus erythematosus patient with cardiac tamponade Ann Rheum Dis 58 720 721 10.1136/ard.58.11.720 1:STN:280:DC%2BD3c%2FlsFCgtw%3D%3D 10610674
36. Z.J. Wang G.P. Reddy M.B. Gotway, et al. 2003 CT and MR imaging of pericardial disease Radiographics 23 S167 S180 10.1148/rg.23si035504 14557510
37. M. Weber C. Hamm 2008 Redefinition of myocardial infarction - relevance of biomarkers Herz 33 115 121 10.1007/s00059-008-3103-7 18344030